Suppliers / Công Ty Cổ Phần Dược Enlie (Enlie Pharma)

Công Ty Cổ Phần Dược Enlie (Enlie Pharma)

Vietnam Updated 9 July 2026

Công Ty Cổ Phần Dược Enlie (Enlie Pharma) is an API and finished-dose manufacturer based in Vietnam. It appears in 83 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
83
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Trazodone DAV (Vietnam) 2
Cetirizine DAV (Vietnam) 1
Cinnarizine DAV (Vietnam) 1
Dapagliflozin DAV (Vietnam) 1
Dimenhydrinate DAV (Vietnam) 1
Entecavir DAV (Vietnam) 1
Lansoprazole DAV (Vietnam) 1
Magnesium Pidolate DAV (Vietnam) 1
Otilonium Bromide DAV (Vietnam) 1
Propranolol DAV (Vietnam) 1
Show all 17 molecules on file
Pyridoxine DAV (Vietnam) 1
Rebamipid DAV (Vietnam) 1
Rupatadine DAV (Vietnam) 1
Ticagrelor DAV (Vietnam) 1
Tofisopam DAV (Vietnam) 1
Trimethoprim DAV (Vietnam) 1
Valganciclovir DAV (Vietnam) 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 83 None

Comparing suppliers?

Choose your molecules and target markets. Công Ty Cổ Phần Dược Enlie (Enlie Pharma) comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability